US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 5.800
  • 0.0000.00%
Trading Nov 4 11:26 ET
604.25MMarket Cap-1801P/E (TTM)

Revance Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.96%-41.13M
5.12%-65.94M
-11.90%-216.58M
-41.58%-42.73M
11.94%-50.96M
-20.71%-53.38M
-13.43%-69.5M
12.63%-193.55M
32.34%-30.18M
-8.85%-57.87M
Net income from continuing operations
44.33%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-9.58%-67.32M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
Depreciation and amortization
-59.53%1.43M
-70.07%1.98M
-65.02%13.69M
-92.28%1.42M
-75.81%2.13M
-46.57%3.53M
23.10%6.62M
97.18%39.15M
239.14%18.38M
70.54%8.78M
Other non cash items
158.92%1.82M
-11.30%738K
-2.15%3.04M
76.27%832K
-55.07%678K
11.62%701K
66.07%832K
165.81%3.11M
396.84%472K
285.93%1.51M
Change In working capital
-143.93%-10.85M
18.79%-23.14M
-6,698.80%-43.88M
-82.53%3.18M
-1,217.26%-14.12M
-654.61%-4.45M
-65.19%-28.49M
113.93%665K
833.80%18.18M
-121.27%-1.07M
-Change in receivables
-271.32%-6.2M
45.22%-2.21M
-104.48%-16.34M
-674.37%-2.26M
-36.29%-8.37M
-49.24%-1.67M
-259.22%-4.03M
-426.00%-7.99M
123.31%394K
-503.93%-6.14M
-Change in inventory
-17.37%-4.71M
72.34%-2.11M
-148.17%-14.91M
428.09%3.16M
-103.04%-6.42M
-36.36%-4.01M
-1,418.69%-7.64M
-40.44%-6.01M
1,473.68%598K
38.37%-3.16M
-Change in prepaid assets
23.59%-1.38M
109.49%123K
-288.79%-6.79M
15.03%5.23M
-829.41%-8.91M
-816.75%-1.81M
-720.10%-1.3M
305.37%3.6M
165.92%4.54M
-111.35%-959K
-Change in payables and accrued expense
89.84%4.52M
-2.76%-18.72M
-81.47%1.88M
-47.85%8.29M
115.00%9.42M
-55.36%2.38M
-17.51%-18.22M
102.28%10.12M
318.95%15.9M
-34.48%4.38M
-Change in other current assets
-2,503.69%-18.89M
103.11%711K
-386.75%-35.5M
-22.65%2.87M
-398.46%-16.33M
-98.51%786K
66.97%-22.83M
49.27%-7.29M
-59.08%3.71M
265.96%5.47M
-Change in other current liabilities
2,819.75%19.42M
-104.01%-958K
407.87%32.07M
-19.38%-5.58M
277.80%14.45M
98.64%-714K
-66.64%23.91M
-54.18%6.31M
-294.76%-4.67M
-2,055.44%-8.13M
-Change in other working capital
-715.87%-3.61M
-98.08%31K
-322.18%-4.29M
-272.16%-8.53M
-72.67%2.04M
263.23%586K
156.03%1.62M
218.33%1.93M
-93.58%-2.29M
2,794.95%7.47M
Cash from discontinued investing activities
Operating cash flow
22.96%-41.13M
5.12%-65.94M
-11.90%-216.58M
-41.58%-42.73M
11.94%-50.96M
-20.71%-53.38M
-13.43%-69.5M
12.63%-193.55M
32.34%-30.18M
-8.85%-57.87M
Investing cash flow
Cash flow from continuing investing activities
82.57%-6.89M
-133.27%-31.71M
179.06%109.74M
-94.21%2.37M
143.55%51.59M
62.66%-39.53M
113.87%95.32M
-367.88%-138.8M
48.19%40.96M
-804.74%-118.45M
Net PPE purchase and sale
1,024.81%2.99M
-494.71%-5.17M
-114.52%-6.89M
-38.12%-1.78M
-349.40%-4.5M
-50.37%266K
40.25%-870K
69.06%-3.21M
70.44%-1.29M
-140.11%-1M
Net investment purchase and sale
88.39%-4.62M
-127.59%-26.54M
204.94%121.51M
-87.23%5.65M
154.30%59.47M
60.39%-39.8M
92.43%96.19M
-899.03%-115.79M
38.22%44.23M
-597.63%-109.52M
Net other investing changes
----
----
75.34%-4.88M
24.24%-1.5M
----
----
----
-157.14%-19.8M
---1.98M
---7.92M
Cash from discontinued investing activities
Investing cash flow
82.57%-6.89M
-133.27%-31.71M
179.06%109.74M
-94.21%2.37M
143.55%51.59M
62.66%-39.53M
113.87%95.32M
-367.88%-138.8M
48.19%40.96M
-804.74%-118.45M
Financing cash flow
Cash flow from continuing financing activities
-103.50%-3.41M
2,743.12%92.83M
-58.83%136.57M
73.61%-1.63M
-82.28%37.46M
360.53%97.47M
-96.90%3.27M
1,010.50%331.69M
-1,624.20%-6.17M
8,582.70%211.39M
Net issuance payments of debt
39.25%-3.9M
-70.03%-4.23M
-65.35%30.16M
55.03%-2.74M
1,390.15%41.8M
-264.38%-6.41M
-102.53%-2.49M
--87.05M
---6.1M
---3.24M
Net common stock issuance
--0
--97.63M
-59.61%100.18M
--0
--0
339.07%100.18M
--0
1,042.61%248.01M
--0
21,620,100.00%216.2M
Proceeds from stock option exercised by employees
-87.59%557K
-99.79%20K
217.20%15.29M
-42.18%1.26M
-88.67%58K
119.19%4.49M
11,901.27%9.48M
-71.12%4.82M
31.46%2.18M
63.06%512K
Net other financing activities
90.48%-75K
84.16%-591K
-10.64%-9.07M
93.44%-148K
-111.19%-4.4M
59.38%-788K
-94.98%-3.73M
3.89%-8.19M
-79.98%-2.26M
25.74%-2.08M
Cash from discontinued financing activities
Financing cash flow
-103.50%-3.41M
2,743.12%92.83M
-58.83%136.57M
73.61%-1.63M
-82.28%37.46M
360.53%97.47M
-96.90%3.27M
1,010.50%331.69M
-1,624.20%-6.17M
8,582.70%211.39M
Net cash flow
Beginning cash position
-2.89%139.93M
25.85%144.75M
-0.56%115.02M
69.13%186.74M
97.31%148.66M
-29.46%144.1M
-0.56%115.02M
-65.68%115.67M
-16.50%110.41M
-55.96%75.34M
Current changes in cash
-1,228.62%-51.43M
-116.57%-4.82M
4,660.12%29.73M
-1,011.83%-41.99M
8.58%38.08M
103.53%4.56M
-67.18%29.08M
99.71%-652K
127.80%4.61M
190.27%35.07M
End cash Position
-40.47%88.5M
-2.89%139.93M
25.85%144.75M
25.85%144.75M
69.13%186.74M
97.31%148.66M
-29.46%144.1M
-0.56%115.02M
-0.56%115.02M
-16.50%110.41M
Free cash flow
28.20%-38.14M
-1.06%-71.11M
-13.57%-223.46M
-41.44%-44.51M
5.79%-55.47M
-21.58%-53.12M
-12.19%-70.37M
15.16%-196.76M
35.73%-31.47M
-16.19%-58.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.96%-41.13M5.12%-65.94M-11.90%-216.58M-41.58%-42.73M11.94%-50.96M-20.71%-53.38M-13.43%-69.5M12.63%-193.55M32.34%-30.18M-8.85%-57.87M
Net income from continuing operations 44.33%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-9.58%-67.32M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M
Depreciation and amortization -59.53%1.43M-70.07%1.98M-65.02%13.69M-92.28%1.42M-75.81%2.13M-46.57%3.53M23.10%6.62M97.18%39.15M239.14%18.38M70.54%8.78M
Other non cash items 158.92%1.82M-11.30%738K-2.15%3.04M76.27%832K-55.07%678K11.62%701K66.07%832K165.81%3.11M396.84%472K285.93%1.51M
Change In working capital -143.93%-10.85M18.79%-23.14M-6,698.80%-43.88M-82.53%3.18M-1,217.26%-14.12M-654.61%-4.45M-65.19%-28.49M113.93%665K833.80%18.18M-121.27%-1.07M
-Change in receivables -271.32%-6.2M45.22%-2.21M-104.48%-16.34M-674.37%-2.26M-36.29%-8.37M-49.24%-1.67M-259.22%-4.03M-426.00%-7.99M123.31%394K-503.93%-6.14M
-Change in inventory -17.37%-4.71M72.34%-2.11M-148.17%-14.91M428.09%3.16M-103.04%-6.42M-36.36%-4.01M-1,418.69%-7.64M-40.44%-6.01M1,473.68%598K38.37%-3.16M
-Change in prepaid assets 23.59%-1.38M109.49%123K-288.79%-6.79M15.03%5.23M-829.41%-8.91M-816.75%-1.81M-720.10%-1.3M305.37%3.6M165.92%4.54M-111.35%-959K
-Change in payables and accrued expense 89.84%4.52M-2.76%-18.72M-81.47%1.88M-47.85%8.29M115.00%9.42M-55.36%2.38M-17.51%-18.22M102.28%10.12M318.95%15.9M-34.48%4.38M
-Change in other current assets -2,503.69%-18.89M103.11%711K-386.75%-35.5M-22.65%2.87M-398.46%-16.33M-98.51%786K66.97%-22.83M49.27%-7.29M-59.08%3.71M265.96%5.47M
-Change in other current liabilities 2,819.75%19.42M-104.01%-958K407.87%32.07M-19.38%-5.58M277.80%14.45M98.64%-714K-66.64%23.91M-54.18%6.31M-294.76%-4.67M-2,055.44%-8.13M
-Change in other working capital -715.87%-3.61M-98.08%31K-322.18%-4.29M-272.16%-8.53M-72.67%2.04M263.23%586K156.03%1.62M218.33%1.93M-93.58%-2.29M2,794.95%7.47M
Cash from discontinued investing activities
Operating cash flow 22.96%-41.13M5.12%-65.94M-11.90%-216.58M-41.58%-42.73M11.94%-50.96M-20.71%-53.38M-13.43%-69.5M12.63%-193.55M32.34%-30.18M-8.85%-57.87M
Investing cash flow
Cash flow from continuing investing activities 82.57%-6.89M-133.27%-31.71M179.06%109.74M-94.21%2.37M143.55%51.59M62.66%-39.53M113.87%95.32M-367.88%-138.8M48.19%40.96M-804.74%-118.45M
Net PPE purchase and sale 1,024.81%2.99M-494.71%-5.17M-114.52%-6.89M-38.12%-1.78M-349.40%-4.5M-50.37%266K40.25%-870K69.06%-3.21M70.44%-1.29M-140.11%-1M
Net investment purchase and sale 88.39%-4.62M-127.59%-26.54M204.94%121.51M-87.23%5.65M154.30%59.47M60.39%-39.8M92.43%96.19M-899.03%-115.79M38.22%44.23M-597.63%-109.52M
Net other investing changes --------75.34%-4.88M24.24%-1.5M-------------157.14%-19.8M---1.98M---7.92M
Cash from discontinued investing activities
Investing cash flow 82.57%-6.89M-133.27%-31.71M179.06%109.74M-94.21%2.37M143.55%51.59M62.66%-39.53M113.87%95.32M-367.88%-138.8M48.19%40.96M-804.74%-118.45M
Financing cash flow
Cash flow from continuing financing activities -103.50%-3.41M2,743.12%92.83M-58.83%136.57M73.61%-1.63M-82.28%37.46M360.53%97.47M-96.90%3.27M1,010.50%331.69M-1,624.20%-6.17M8,582.70%211.39M
Net issuance payments of debt 39.25%-3.9M-70.03%-4.23M-65.35%30.16M55.03%-2.74M1,390.15%41.8M-264.38%-6.41M-102.53%-2.49M--87.05M---6.1M---3.24M
Net common stock issuance --0--97.63M-59.61%100.18M--0--0339.07%100.18M--01,042.61%248.01M--021,620,100.00%216.2M
Proceeds from stock option exercised by employees -87.59%557K-99.79%20K217.20%15.29M-42.18%1.26M-88.67%58K119.19%4.49M11,901.27%9.48M-71.12%4.82M31.46%2.18M63.06%512K
Net other financing activities 90.48%-75K84.16%-591K-10.64%-9.07M93.44%-148K-111.19%-4.4M59.38%-788K-94.98%-3.73M3.89%-8.19M-79.98%-2.26M25.74%-2.08M
Cash from discontinued financing activities
Financing cash flow -103.50%-3.41M2,743.12%92.83M-58.83%136.57M73.61%-1.63M-82.28%37.46M360.53%97.47M-96.90%3.27M1,010.50%331.69M-1,624.20%-6.17M8,582.70%211.39M
Net cash flow
Beginning cash position -2.89%139.93M25.85%144.75M-0.56%115.02M69.13%186.74M97.31%148.66M-29.46%144.1M-0.56%115.02M-65.68%115.67M-16.50%110.41M-55.96%75.34M
Current changes in cash -1,228.62%-51.43M-116.57%-4.82M4,660.12%29.73M-1,011.83%-41.99M8.58%38.08M103.53%4.56M-67.18%29.08M99.71%-652K127.80%4.61M190.27%35.07M
End cash Position -40.47%88.5M-2.89%139.93M25.85%144.75M25.85%144.75M69.13%186.74M97.31%148.66M-29.46%144.1M-0.56%115.02M-0.56%115.02M-16.50%110.41M
Free cash flow 28.20%-38.14M-1.06%-71.11M-13.57%-223.46M-41.44%-44.51M5.79%-55.47M-21.58%-53.12M-12.19%-70.37M15.16%-196.76M35.73%-31.47M-16.19%-58.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data